IRTC
IRTC
NASDAQ · Health Care

Irhythm Holdings Inc

$90.22
-39.97 (-30.70%)
As of Nov 7, 1:29 AM ET ·
Financial Highlights (FY 2026)
Revenue
750.67M
Net Income
-44,760,529
Gross Margin
70.6%
Profit Margin
-6.0%
Rev Growth
+22.1%
D/E Ratio
4.25
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 70.6% 70.6% 36.4% 36.4%
Operating Margin -7.7% -6.9% 12.1% 15.0%
Profit Margin -6.0% -5.7% 12.0% 14.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 750.67M 615.05M 1.48B 1.53B
Gross Profit 529.75M 434.04M 539.48M 555.34M
Operating Income -57,651,809 -42,512,599 179.99M 228.68M
Net Income -44,760,529 -33,006,535 177.25M 225.68M
Gross Margin 70.6% 70.6% 36.4% 36.4%
Operating Margin -7.7% -6.9% 12.1% 15.0%
Profit Margin -6.0% -5.7% 12.0% 14.8%
Rev Growth +22.1% +22.1% +2.2% -3.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.17B 1.17B 326.12M 362.93M
Total Equity 276.18M 276.18M 2.53B 2.36B
D/E Ratio 4.25 4.25 0.13 0.15
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -36,837,401 -28,673,110 234.45M 287.53M
Free Cash Flow — — 120.95M 142.43M